KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 126 filers reported holding KALA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $175,000 | -26.5% | 787,252 | -0.8% | 0.00% | – |
| Q2 2022 | $238,000 | -94.5% | 793,477 | -74.6% | 0.00% | – |
| Q1 2022 | $4,316,000 | +13.7% | 3,127,650 | -0.2% | 0.00% | – |
| Q4 2021 | $3,795,000 | -60.5% | 3,134,773 | -14.5% | 0.00% | – |
| Q3 2021 | $9,601,000 | -51.3% | 3,664,849 | -1.5% | 0.00% | -100.0% |
| Q2 2021 | $19,712,000 | -11.8% | 3,719,412 | +12.1% | 0.00% | 0.0% |
| Q1 2021 | $22,359,000 | +4.3% | 3,317,347 | +5.0% | 0.00% | 0.0% |
| Q4 2020 | $21,429,000 | +11.3% | 3,160,506 | +23.1% | 0.00% | 0.0% |
| Q3 2020 | $19,254,000 | -34.9% | 2,567,236 | -8.8% | 0.00% | 0.0% |
| Q2 2020 | $29,575,000 | +112.7% | 2,813,940 | +77.9% | 0.00% | 0.0% |
| Q1 2020 | $13,906,000 | +164.7% | 1,581,889 | +11.1% | 0.00% | – |
| Q4 2019 | $5,253,000 | -21.5% | 1,423,606 | -19.0% | 0.00% | – |
| Q3 2019 | $6,689,000 | -37.8% | 1,758,004 | +4.3% | 0.00% | – |
| Q2 2019 | $10,749,000 | -7.2% | 1,684,802 | +20.3% | 0.00% | -100.0% |
| Q1 2019 | $11,588,000 | +66.0% | 1,401,055 | -1.9% | 0.00% | – |
| Q4 2018 | $6,980,000 | -36.0% | 1,427,672 | +29.2% | 0.00% | – |
| Q3 2018 | $10,910,000 | -16.0% | 1,105,361 | +16.8% | 0.00% | -100.0% |
| Q2 2018 | $12,994,000 | -18.5% | 946,478 | -6.1% | 0.00% | 0.0% |
| Q1 2018 | $15,951,000 | +16.9% | 1,007,691 | +36.5% | 0.00% | 0.0% |
| Q4 2017 | $13,646,000 | +42.6% | 738,050 | +76.1% | 0.00% | – |
| Q3 2017 | $9,570,000 | – | 419,007 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,430,021 | $9,638,000 | 6.26% |
| RA Capital Management | 10,874,613 | $73,295,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 41,961 | $283,000 | 0.77% |
| Samsara BioCapital, LLC | 601,162 | $4,052,000 | 0.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $689,000 | 0.38% |
| Eventide Asset Management | 3,450,000 | $23,253,000 | 0.34% |
| Orbimed Advisors | 5,465,030 | $36,834,000 | 0.34% |
| Parkman Healthcare Partners LLC | 148,433 | $1,000,000 | 0.23% |
| Vivo Capital, LLC | 786,883 | $5,304,000 | 0.19% |
| Knights of Columbus Asset Advisors LLC | 199,954 | $1,348,000 | 0.13% |